Group One Trading’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-5,000
Closed -$13.4K 8191
2022
Q4
$13.4K Buy
+5,000
New +$13.2K ﹤0.01% 5867
2022
Q3
Sell
-200
Closed -$1K 8493
2022
Q2
$1K Sell
200
-24,600
-99% -$129K ﹤0.01% 7671
2022
Q1
$176K Sell
24,800
-1,500
-6% -$12.4K ﹤0.01% 4934
2021
Q4
$478K Buy
26,300
+1,200
+5% +$25.9K ﹤0.01% 4182
2021
Q3
$491K Buy
+25,100
New +$955K ﹤0.01% 4202
2021
Q2
Sell
-3,900
Closed -$196K 8708
2021
Q1
$196K Hold
3,900
﹤0.01% 5054
2020
Q4
$349K Buy
+3,900
New +$328K ﹤0.01% 3596

Other funds holding CELL

Group One Trading's CELL Position: Q4 2022 in Review

Group One Trading sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2022, closing a stake of 2,413 shares — an estimated $6.36K sold.

Group One Trading first reported a position in CELL in Q3 2021 and held it in 5 quarters. The position peaked at $465K in Q4 2021. 117 funds tracked by Wall St. Rank hold CELL as of Q4 2022.

  • Group One Trading reported no remaining PhenomeX Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Group One Trading sold 2,413 PhenomeX Inc. Common Stock shares in Q4 2022, an estimated $6.36K.
  • Group One Trading first reported a position in PhenomeX Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • Group One Trading's PhenomeX Inc. Common Stock position peaked at $465K in Q4 2021.
  • 117 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2022.

Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.